Related Experiment Video

Updated: Feb 22, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.4K

PP2A regulates signaling through hormonal receptors in breast cancer with important therapeutic implications

Ion Cristóbal1, Blanca Torrejón1, Javier Martínez-Useros1

  • 1Translational Oncology Division, Oncohealth Institute, IIS-Fundacion Jimenez Diaz, UAM, University Hospital "Fundacion Jimenez Diaz", Madrid, Spain.

Biochimica Et Biophysica Acta. Reviews on Cancer
|September 17, 2017
PubMed

Insights

Protein phosphatase 2A (PP2A) inhibition is common in breast cancer, worsening outcomes. This review details how PP2A impacts estrogen and androgen receptor signaling, influencing breast cancer progression and treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Functional inhibition of protein phosphatase 2A (PP2A) is a frequent alteration in breast cancer.
  • PP2A inhibition correlates with poor prognosis, increased disease progression, and aggressiveness.
  • Estrogen receptor (ER) and androgen receptor (AR) signaling are critical in breast cancer pathogenesis and therapeutics.

Purpose of the Study:

  • To review the role of the tumor suppressor PP2A in modulating ER and AR signaling in breast cancer.
  • To elucidate the molecular mechanisms underlying PP2A's influence on these receptors.
  • To discuss the biological and therapeutic implications of PP2A's impact on ER and AR signaling.

Main Methods:

  • Literature review of studies investigating PP2A, ER, and AR signaling in breast cancer.
  • Analysis of molecular mechanisms by which PP2A affects ER and AR.
  • Synthesis of data on the clinical and therapeutic relevance.

Main Results:

  • PP2A acts as a tumor suppressor by modulating ER and AR signaling pathways.
  • Dysregulation of PP2A impacts key pathways driving breast cancer growth and metastasis.
  • Understanding PP2A's role offers potential for novel therapeutic strategies targeting ER/AR signaling.

Conclusions:

  • PP2A plays a crucial role in regulating ER and AR signaling in breast cancer.
  • Targeting PP2A or its downstream pathways could offer new therapeutic avenues for breast cancer treatment.
  • Further research into PP2A's precise mechanisms is warranted for clinical application.
Keywords:
ARBreast cancerEREnzalutamidePP2ATamoxifen

More Related Videos

An Ex vivo Model to Study Hormone Action in the Human Breast12:31

An Ex vivo Model to Study Hormone Action in the Human Breast

Published on: January 8, 2015

12.0K
Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer10:36

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Published on: March 17, 2016

11.0K

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.4K
Secondary Messengers in Hormone Action01:26

Secondary Messengers in Hormone Action

Water-soluble hormones cannot cross the plasma membrane, so they rely on protein receptors that span the membrane to trigger intracellular signaling pathways. These pathways then activate second messengers inside the cell, including cAMP or calcium ions.
Many hormones bind to transmembrane G protein-coupled receptors that connect to regulatory G proteins. These G proteins can then activate enzymes such as adenylyl cyclase or phospholipase C. Adenylyl cyclase converts ATP to cAMP, activating...
5.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.8K